Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle

Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle

Botulism is a potentially fatal intoxication caused by botulinum neurotoxins (BoNTs) produced mainly by Clostridium botulinum. Vaccination against BoNT serotypes C and D is the main procedure to control cattle botulism. Current vaccines contain formaldehyde-inactivated native BoNTs, which have a tim...

Full description

Bibliographic Details
Main Authors:	Clóvis Moreira, Marcos R. A. Ferreira, Carlos E. P. da Cunha, Rafael A. Donassolo, Paula F. Finger, Gustavo M. S. G. Moreira, Denis Y. Otaka, Loise A. de Sousa, José D. Barbosa, Ângela N. Moreira, Felipe M. Salvarani, Fabricio R. Conceição
Format:	Article
Language:	English
Published:	MDPI AG 2018-09-01
Series:	Toxins
Subjects:	Clostridium botulinum vaccine botulinum neurotoxin (BoNT) cell lysate vaccine
Online Access:	http://www.mdpi.com/2072-6651/10/10/381

Similar Items

Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D
by: Denis Y. Otaka, et al.
Published: (2017-09-01)

Botulinum neurotoxin X lacks potency in mice and in human neurons
by: Brieana M. Gregg, et al.
Published: (2024-03-01)

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01)

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
by: Sylvia Valdezate, et al.
Published: (2023-10-01)

Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
by: Christine Rasetti-Escargueil, et al.
Published: (2019-09-01)

Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM
by: Sara Košenina, et al.
Published: (2021-12-01)

Variability of Botulinum Toxins: Challenges and Opportunities for the Future
by: Christine Rasetti-Escargueil, et al.
Published: (2018-09-01)

Type C waterborne botulism outbreaks in buffaloes (Bubalus bubalis) in the Amazon region
by: Felipe M. Salvarani, et al.

Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors
by: Jonathan R. Davies, et al.
Published: (2020-09-01)

Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay
by: Ilenia Drigo, et al.
Published: (2020-12-01)

Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01)

Therapeutic Applications of Botulinum Neurotoxins in Veterinary Medicine
by: Lauretta Turin, et al.
Published: (2023-07-01)

Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
by: Guorui Yao, et al.
Published: (2017-03-01)

Genomic Diversity, Competition, and Toxin Production by Group I and II <i>Clostridium botulinum</i> Strains Used in Food Challenge Studies
by: Brooke Kathryn Bowe, et al.
Published: (2022-09-01)

Sheep Monoclonal Antibodies Prevent Systemic Effects of Botulinum Neurotoxin A1
by: Charles B. Shoemaker, et al.
Published: (2012-12-01)

The 25 kDa H<sub>CN</sub> Domain of Clostridial Neurotoxins Is Indispensable for Their Neurotoxicity
by: Julian Deppe, et al.
Published: (2020-11-01)

Botulinum toxin (BoNT) in the correction of mimic wrinkles - the most common complications
by: Monika Szwed, et al.
Published: (2022-08-01)

The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion
by: Bin Lu
Published: (2015-06-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Animal botulism in Poland – laboratory and epidemiological investigations
by: Grenda Tomasz, et al.
Published: (2022-05-01)

Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E
by: Candace S. Bever, et al.
Published: (2019-07-01)

Botulism: A Frequently Forgotten Old Malady
by: Teguh Thajeb, et al.
Published: (2007-09-01)

International Proficiency Test Targeting a Large Panel of Botulinum Neurotoxin Sero- and Subtypes in Different Matrices
by: Christine Rasetti-Escargueil, et al.
Published: (2024-11-01)

Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing
by: Sabine Pellett, et al.
Published: (2015-11-01)

Molecular Diversity of BoNT-Producing Clostridia—A Still-Emerging and Challenging Problem
by: Tomasz Grenda, et al.
Published: (2023-03-01)

Botulism outbreak in cattle due to ingestion of accidental deteriorated feed
by: Milena Carolina Paz, et al.
Published: (2024-12-01)

Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson’s disease
by: Bruno Bergmans, et al.
Published: (2023-01-01)

Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
by: Andrea Pathe-Neuschäfer-Rube, et al.
Published: (2018-09-01)

Engineering of Botulinum Neurotoxins for Biomedical Applications
by: Robert P. Webb
Published: (2018-06-01)

Toxemia in Human Naturally Acquired Botulism
by: Christine Rasetti-Escargueil, et al.
Published: (2020-11-01)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
by: Lmar Babrak, et al.
Published: (2016-01-01)

Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool
by: Karen Perrow, et al.
Published: (2011-01-01)

Botulinum Toxin for Neuropathic Pain: A Review of the Literature
by: Hyun-Mi Oh, et al.
Published: (2015-08-01)

The First Case of Botulism in a Donkey
by: Aliai Lanci, et al.
Published: (2019-05-01)

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study
by: Cynthia Comella, et al.
Published: (2022-01-01)

Emergence of Novel Type C Botulism Strain in Household Outbreak, Japan
by: Rika Maeda, et al.
Published: (2023-10-01)

Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials
by: Lorenzo Lippi, et al.
Published: (2024-03-01)

Botulinum toxin in the treatment of neuralgia and neuropathic pain
by: Katarzyna Mielniczek
Published: (2021-09-01)

Public Health Risk Associated with Botulism as Foodborne Zoonoses
by: Christine Rasetti-Escargueil, et al.
Published: (2019-12-01)

Botulism in Brazil, 2000-2008: epidemiology, clinical findings and laboratorial diagnosis Botulismo no Brasil, 2000-2008: epidemiologia, achados clínicos e diagnóstico laboratorial
by: Ruth Estela Gravato Rowlands, et al.
Published: (2010-08-01)